TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanismKaikai Zhao(Binzhou Medical University), Xiangjiao Meng(Shandong First Medical University)Cancer Immunology ImmunotherapyJuly 6, 202210.1007/s00262-022-03227-zCited by 24SaveCiteExport RISWatch citationsRelated PapersA B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial|Nature Medicine|2025|76Prophylactic cranial irradiation (PCI) versus active surveillance in patients with limited-stage small cell lung cancer: a retrospective, multicentre study|Respiratory Research|2022|17